Form 4: Entera Bio Director Gerald Lieberman Reports Share Acquisition and Disposal
SEC Form 4 Filing
Director Gerald Lieberman reports acquiring 27,261 shares and disposing of 254,222 shares of Entera Bio Ltd. on August 27, 2024.
Summary
- On August 27, 2024, Gerald Lieberman, a director of Entera Bio Ltd., reported a transaction involving the company's ordinary shares.
- Lieberman acquired 27,261 ordinary shares at a price of $0.
- Simultaneously, Lieberman disposed of 254,222 ordinary shares.
- Following these transactions, Lieberman directly owns 27,261 shares.
- Lieberman also indirectly owns 6,200 shares each through four different trusts, where his grandchild is the beneficiary and his spouse is the trustee.
- Lieberman disclaims beneficial ownership of the shares held by these trusts, except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider trading activities.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of the transaction involving the acquisition and disposal of Entera Bio Ltd. ordinary shares. |
| 08/29/2024 | Date of signature by Attorney-in-Fact Dana Yaacov-Garbeli. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.